For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Bevacizumab and Vitrectomy | 0.16mg/0.05ml bevacizumab intravitreal injection one day before surgery and vitrectomy. Bevacizumab: 0.16mg/0.05ml bevacizumab (single injection on 1 day before operation) Vitrectomy: vitrectomy of 25 gauge system. | None | None | 0 | 32 | 0 | 32 | View |
| Sham Injection and Vitrectomy | Sham injection one day before operation and vitrectomy. Vitrectomy: vitrectomy of 25 gauge system. Sham injection: Sham injection one day before vitrectomy | None | None | 0 | 34 | 0 | 34 | View |